VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma

Renal cell carcinoma (RCC) is currently one of the most treatment-resistant malignancies and affects approximately three in 10,000 people. The impact of this disease produces about 31,000 new cases in the United States per year; and 12,000 people in the United States alone die from RCC annually. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Sutapa, Cao, Ying, Dutta, Shamit, Wang, Enfeng, Mukhopadhyay, Debabrata
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992850/
https://www.ncbi.nlm.nih.gov/pubmed/19017359
http://dx.doi.org/10.1111/j.1582-4934.2008.00578.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992850/
https://www.ncbi.nlm.nih.gov/pubmed/19017359
http://dx.doi.org/10.1111/j.1582-4934.2008.00578.x

Ejemplares similares